SCHEMBL35211521

SCHEMBL35211521

Cn1c(=O)c(C(N)=O)cc2ncncc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.35
▸ CYP1A2 P05177 6/20 0.34
▸ CYP3A4 P08684 5/20 0.34
▸ TSHR P16473 4/20 0.34
▸ CLK4 Q9HAZ1 3/20 0.34
▸ RPS6KB1 P23443 2/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ BRPF1 P55201 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ KCNH2 Q12809 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ SIK1 P57059 1/20 0.32
▸ SIK2 Q9H0K1 1/20 0.32
▸ SIK3 Q9Y2K2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6061273 0.77 SYK (0.41) MAPK1ALDH1A1HSD17B10KDM4EBRD4
SCHEMBL30539577 0.77 SYK (0.41) MAPK1ALDH1A1HSD17B10KDM4EBRD4
SCHEMBL35211579 0.73 KDM4E (0.48) MAPK1CLK4KDM4EAHRSIRT3
SCHEMBL35212407 0.71 MAPK1 (0.37) MAPK1CLK4ALDH1A1CNR2HSD17B10
SCHEMBL35211826 0.71 SIRT3 (0.45) MAPK1CLK4ALDH1A1HSD17B10KDM4E
SCHEMBL35211552 0.71 PARP1 (0.41) MAPK1ALDH1A1HSD17B10KDM4EBRD4
SCHEMBL13041966 0.70 CASP1 (0.35) CYP1A2CYP3A4TSHRCLK4ALDH1A1
SCHEMBL29638555 0.69 RPS6KB1 (0.40) RPS6KB1KDM4ESIRT3TDP1
SCHEMBL35211498 0.67 PKN1 (0.36) RPS6KB1
SCHEMBL20223112 0.66 BRPF1 (0.40) CYP1A2CYP3A4TSHRCLK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124198-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS GILEAD SCIENCES INC (US) 2026-05-07 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260124198-A1 ANTIVIRAL PYRAZOLOPYRIDINONE COMPOUNDS ZC3HAV1, CCR1, CCR6 MAPK1 1285/4885CYP1A2 2035/4885CYP3A4 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback